In vitro study of regulation of IL-6 production in bronchiectasis

Respiratory Medicine

Volumn 98, Issue 4, 2004, Pages 334-341

  Ho, James C ^a   Tipoe, George ^a   Zheng, L ^a   Leung, T M ^a   Tsang, Kenneth W T ^a   Shum, Daisy K Y ^a   Lau, C S ^a   Mak, Judith C W ^a   Lam, W K ^a   Ip, Mary S M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bronchiectasis; Drug modulation; Interleukin 6

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; ETORICOXIB; IBUPROFEN; INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; BRONCHUS MUCOSA; CELL CULTURE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; SPUTUM ANALYSIS; STATISTICAL ANALYSIS;

EID: 11144358561     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2003.10.012     Document Type: Article

References (42)

1. Ip MS, Lam WK. Bronchiectasis and related disorders. Respirology 1996;1:107-14.
2. Tsang KW, Chan KN, Ho PL, et al. Sputum elastase in steady-state bronchiectasis. Chest 2000;117:420-6.
3. Ip M, Lam WK, Chan JC, Liong E. Systemic effects of inflammation in bronchiectasis. Respir Med 1991;85:521-5.
4. Ip M, Shum D, Lauder I, Lam WK, So SY. Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis. Respir Med 1993;87:449-54.
5. Thompson PJ. Unique role of allergens and the epithelium in asthma. Clin Exp Allergy 1998;28(Suppl 5):110-6.
6. Khair OA, Davies RJ, Devalia JL. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996;9:1913-22.
7. Barton BE. IL-6: Insights into novel biological activities. Clin Immunol Immunopathol 1997;85:16-20.
8. Angrill J, Agusti C, De Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001;164:1628-32.
9. Osika E, Cavaillon JM, Chadelat K, et al. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 1999;14:339-46.
10. Nixon LS, Yung B, Bell SC, Elborn JS, Shale DJ. Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 1998;157:1764-9.
11. Kupchan SM, Court WA, Dailey RG, Gilmore CJ, Bryan RF. Triptolide and triptodiolide, novel antileukemic diterpenoid trepoxides from Tripterygium wilfordii. Isolation of metabolites of interest in rheumatoid arthritis, immunosuppression and male contraceptive activity. Can J Chem 1972; 70:1455-80.
12. Donnelly LE, Barnes PJ. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. Am J Respir Cell Mol Biol 2002;26:144-51.
13. - secretion. J Clin Invest 1998;102:679-87.
14. Liu H, Liu ZH, Chen ZH, Yang JW, Li LS. Triptolide: A potent inhibitor of NF-kappa B in T-lymphocyte. Acta Pharmacol Sin 2000;21:782-6.
15. Shum DK, Chan SC, Ip MS. Neutrophil-mediated degradation of lung proteoglycans: Stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis. Am J Respir Crit Care Med 2000;162:1925-31.
16. Zhao G, Vaszar LT, Qiu D, Shi L, Kao PN. Anti-inflammatory effects of triptolide in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000;279:L958-66.
17. Striz I, Mio T, Adachi Y, Carnevali S, Romberger DJ, Rennard SI. Effects of interferons alpha and gamma on cytokine production and phenotypic pattern of human bronchial epithelial cells. Int J Immunopharmacol 2000;22:573-85.
18. McKay S, Hirst SJ, Haas MB, et al. Tumor necrosis factor-α enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells. Am J Respir Cell Mol Biol 2000;23:103-11.
19. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000;51:207-29.
20. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
21. Haworth C, Brennan FM, Chantry D, Turner M, Maini RN, Feldmann M. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor-alpha. Eur J Immunol 1991;21: 2575-7.
22. Butler DM, Maini RN, Feldmann M, Brennan FM. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 1995;6:225-30.
23. Li YH, Brauner A, Jonsson B, et al. Inhibition of macrophage proinflammatory cytokine expression by steroids and recombinant IL-10. Biol Neonate 2001;80:124-32.
24. Suzuki T, Yamaya M, Sekizawa K, et al. Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000;278:L560-71.
25. Endres S, Whitaker RE, Ghorbani R, Meydani SN, Dinarello CA. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo. Immunology 1996;87:264-70.
26. Sironi M, Gadina M, Kankova M, et al. Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice. Int J Immunopharmacol 1992;14:1045-50.
27. Mansilla-Rosello A, Ferron-Orihuela JA, Ruiz-Cabello F, Garrote-Lara D, Fernandez-Mondejar E, Delgado-Carrasco ML. Differential effects of IL-1 beta and ibuprofen after endotoxic challenge in mice. J Surg Res 1997;67:199-204.
28. Sirota L, Shacham D, Punsky I, Bessler H. Ibuprofen affects pro- and anti-inflammatory cytokine production by mononuclear cells of preterm newborns. Biol Neonate 2001;79:103-8.
29. Leeper-Woodford SK, Carey D, Byrne K, et al. Histamine receptor antagonists, cyclooxygenase blockade, and tumor necrosis factor during acute septic insult. Shock 1998;9: 89-94.
30. Stuhlmeier KM, Li H, Kao JJ. Ibuprofen: New explanation for an old phenomenon. Biochem Pharmacol 1999;57: 313-20.
31. Mancuso G, Cusumano V, Cook JA, et al. Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol Med Microbiol 1994;9:49-54.
32. Komatsu H, Yaju H, Chiba K, Okumoto T. Inhibition by cyclo-oxygenase inhibitors of interleukin-6 production by human peripheral blood mononuclear cells. Int J Immunopharmacol 1991;13:1137-46.
33. Berg J, Fellier H, Christoph T, Grarup J, Stimmeder D. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX) -1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res 1999;48:369-79.
34. Everts B, Wahrborg P, Hedner T. COX-2-specific inhibitors - the emergence of a new class of analgesic and anti-inflammatory drugs. Clin Rheumatol 2000;19:331-43.
35. Matheson AJ, Figgitt DP. Rofecoxib: A review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis. Drugs 2001;61:833-65.
36. Bensen WG. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: From investigational trials to clinical experience. J Rheumatol 2000;60:17-24.
37. Clemett D, Goa KL. Celecoxib: A review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs 2000;59:957-80.
38. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996;97:2672-9.
39. Chen BJ. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium Wilfordii Hook F. Leuk Lymphoma 2001; 42:253-65.
40. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-72.
41. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-20.
42. Tsang KW, Ho PL, Lam WK, Ip MS, Chan KN, Ho CS, Ooi GC, Yuen KY. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998;158:723-7.